Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas-Reference-Cited by-同舟云学术

Combinatorial drug screening and molecular profiling reveal diverse mechanisms of intrinsic and adaptive resistance to BRAF inhibition in V600E BRAF mutant melanomas

Published:2015-12-10 Issue:3 Volume:7 Page:2734-2753
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Roller Devin G.¹,Capaldo Brian²,Bekiranov Stefan²,Mackey Aaron J.³,Conaway Mark R.³,Petricoin Emanuel F.⁴,Gioeli Daniel¹,Weber Michael J.¹

Affiliation:

1. Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA, 22908 USA

2. Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, 22908 USA

3. Department of Public Health Sciences, University of Virginia, Charlottesville, VA, 22908 USA

4. Center for Applied Proteomics and Molecular Medicine, School of Systems Biology, College of Science, George Mason University, Manassas, VA 20110, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers;Receptors;2024-03-04

2. Myo1e overexpression in lung adenocarcinoma is associated with increased risk of mortality;Scientific Reports;2023-03-13

3. The potentiative cytotoxic effect of IGF1R and EGFR inhibition on the Head and Neck Cancer Proteome;2022-10-14

4. BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors;Frontiers in Oncology;2022-04-04

5. PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma;Scientific Reports;2021-05-26